Selina finds her voice by speaking up

On-screen Text:

SELINA
FINDS HER VOICE
BY SPEAKING UP

NARRATOR (VO):
We invited one dermatologist and four patients to speak openly about psoriasis.

On-screen Text:
Dr. Ackerman is a paid consultant for AbbVie.

On-screen Text:
Patients were on prescribed SKYRIZI (risankizumab-rzaa) therapy at the time of providing a testimonial. Changes in therapy may have occurred since that time. Individual results may vary.

BRETT (VO):
Paint a story of the first time you noticed your psoriasis symptoms.

SELINA (VO):
Mine started on my face, um, under my eyes.

On-screen Text:
SELINA
Diagnosed with moderate plaque psoriasis

SELINA (VO):
I’d just had a baby, a newborn, in February of 2020.

On-screen Text:
SELINA
SKYRIZI patient since 2020

SELINA (VO):
I have no pictures with my newborn really because it was so embarrassing.

SELINA (VO):
I didn't know what questions to ask, especially to my…

On-screen Text:
SKYRIZI is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).

SELINA (VO):
…family. Coming from…

SELINA (VO):
…a Mexican culture, my Nana said, ‘Throw some aloe vera on it.’

On-screen Text:
Please keep watching for Important Safety Information.

SELINA (VO):
After a couple of months, it…

SELINA (VO):
…start spreading. At that point, I was like, okay, ‘Who else could I talk to?’

WILL (VO):
Right.

SELINA (VO):
And that’s when I got referred to a dermatologist.

SELINA (VO):
We really found what worked best for me to get the results that I was looking for.

SELINA (VO):
After the first two doses of…

On-screen Text:
In clinical trials, 3 out of 4 people on SKYRIZI achieved 90% clearer skin at 4 months.

SELINA (VO):
…SKYRIZI, I knew something was working and,…

SELINA (VO):
…I felt that relief.

SELINA (VO):
So, by researching, asking those…

On-screen Text:
Selina and her doctor discussed the side effects, risks, and safety profile of SKYRIZI.

SELINA (VO):
…probing questions with your dermatologist,...

SELINA (VO):
…you’re gonna find that diagnosis a lot faster. And that’s something I wish I knew.

WILL (VO):
You should know there’s help out there.

SELINA (VO):
Yep.

DR. ACKERMAN (VO):
Yeah.

SELINA (VO):
Walk us through your story about your plaque psoriasis.

SELINA (VO):
It was overwhelming to see visible plaque on areas that can be seen to everybody…

SELINA (VO):
…my hands, my feet, my face, very scaly,…

SELINA (VO):
…plaque-y, just not pretty.

SELINA (VO):
Washing the dishes or going out and grilling while my kids are playing outside—I didn't want to do any of that…

SELINA (VO):
My skin has...

SELINA (VO):
…changed significantly since I started using SKYRIZI.

SELINA (VO):
Now that I have clearer skin,…

SELINA (VO):
…I feel free to wear short sleeves...

SELINA (VO):
…and still be outside grilling.

SELINA (VO):
You are your advocate. You know your body.

SELINA (VO):
Go see your dermatologist. Keep going back. Keep talking to them.

SELINA (VO):
Don’t stop that conversation until you feel heard, and you feel that you are getting some answers.

SELINA (VO):
Having clearer skin is everything to me.

On-screen Text:
Please keep watching for Important Safety Information.

V.O./On-Screen Text:
USE AND IMPORTANT SAFETY INFORMATION

SKYRIZI® (risankizumab-rzaa) USE
SKYRIZI is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).

Important Safety Information
What is the most important information I should know about SKYRIZI ® (risankizumab-rzaa)?

SKYRIZI is a prescription medicine that may cause serious side effects, including: 

Serious allergic reactions: 

  • Stop using SKYRIZI and get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction: 
    -  fainting, dizziness, feeling lightheaded (low blood pressure)
    -  swelling of your face, eyelids, lips, mouth, tongue, or throat
    -   trouble breathing or throat tightness
    -  chest tightness
    -  skin rash, hives
    -  itching

Infections:
SKYRIZI may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with SKYRIZI and may treat you for TB before you begin treatment with SKYRIZI if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with SKYRIZI.

  •  Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
    - fever, sweats, or chills
    - cough
    - shortness of breath
    - blood in your mucus (phlegm)
    - muscle aches
    - warm, red, or painful skin or sores on your body different from your psoriasis 
    - weight loss
    - diarrhea or stomach pain
    - burning when you urinate or urinating more often than normal

Do not use SKYRIZI if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI. See the Medication Guide or Consumer Brief Summary for a complete list of ingredients.

Before using SKYRIZI, tell your healthcare provider about all of your medical conditions, including if you:

  • have any of the conditions or symptoms listed in the section “What is the most important information I should know about SKYRIZI?”
  • have an infection that does not go away or that keeps coming back.
  • have TB or have been in close contact with someone with TB.
  • have recently received or are scheduled to receive an immunization (vaccine). Medications that interact with the immune system may increase your risk of getting an infection after receiving live vaccines. You should avoid receiving live vaccines right before, during, or right after treatment with SKYRIZI. Tell your healthcare provider that you are taking SKYRIZI before receiving a vaccine.
  • are pregnant or plan to become pregnant. It is not known if SKYRIZI can harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if SKYRIZI passes into your breast milk.
  • become pregnant while taking SKYRIZI. You are encouraged to enroll in the Pregnancy Registry, which is used to collect information about the health of you and your baby. Talk to your healthcare provider or call 1-877-302-2161 to enroll in this registry.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of SKYRIZI?
SKYRIZI may cause serious side effects. See “What is the most important information I should know about SKYRIZI?”

The most common side effects of SKYRIZI in people treated for plaque psoriasis and psoriatic arthritis include: upper respiratory infections, headache, feeling tired, injection site reactions, and fungal skin infections.

These are not all the possible side effects of SKYRIZI. Call your doctor for medical advice about side effects.

Use SKYRIZI exactly as your healthcare provider tells you to use it.

SKYRIZI is available in a 150 mg/mL prefilled syringe and pen.

Please see the Full Prescribing Information, including the Medication Guide, for SKYRIZI.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.

© 2025 AbbVie. All rights reserved. SKYRIZI® and its design are registered trademarks of AbbVie Biotechnology Ltd.

US-SKZD-250111